Giant cell glioblastoma: Review of the literature and illustrated case

Neurocirugia

Volumn 19, Issue 4, 2008, Pages 343-349

  Valle Folgueral, J M ^a   Mascarenhas, Lino ^a,b   Costa, J A ^a   Vieira, F ^a   Soares Fernandes, J ^a   Beleza, P ^a   Alegria, C ^a  

^a Sao Marcos Hospital   (Portugal)

^b HOSPITAL DE BRAGA   (Portugal)

Author keywords

Giant cell glioblastoma; Leptomeningeal metastases; Radiotherapy; Surgery; Temozolomide

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN P53; PROTEIN S 100; RETICULIN; TEMOZOLOMIDE;

ADJUVANT THERAPY; ADULT; ARTICLE; CASE REPORT; DYSPHASIA; GIANT CELL GLIOBLASTOMA; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MENINGEAL METASTASIS; NUCLEAR MAGNETIC RESONANCE; PROGNOSIS; SURVIVAL; TEMPORAL LOBE;

EID: 53649111790     PISSN: 11301473     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-1473(08)70221-5     Document Type: Article

References (51)

1. Akslen, L.A., Mork, S.J., Larsen, J.L., et al.: Giant cell glioblastoma: a work-up of 2 cases with long survival. Acta Neurol. Scand. 1989; 79: 194-199.
2. Al-Saleem, T., Wessner, L.L., Scheithauer, B.W., et al.: Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex. Cancer 1998; 83: 2208-2216.
3. Alvarez-Betancourt, L., López-Ortega, S., Caldera-Duarte, A.: Giant cell glioblastoma. Case report. [in Spanish] Gac. Med. Mex. 2004; 140: 341-342.
4. Arslantas, A., Artan, S., Oner, U., et al.: The importance of genomic copy number changes in the prognosis of glioblastoma multiforme. Neurosurg. Rev. 2004; 27: 58-64.
5. Bigner, S.H., Burger, P.C., Wong, A.J., et al.: Gene amplification in malignant human gliomas: clinical and histopathologic aspects. J. Neuropathol. Exp. Neurol. 1988; 47: 191-205.
6. Burger, P.C., Vollmer, R.T.: Histologic factors of prognostic significance in the glioblastoma multiforme. Cancer 1980; 46: 1179-1186.
7. Burnstine, M.A., Levin, L.A., Louis, D.N., et al.: Nucleolar organizer regions in optic gliomas. Brain 1993; 116: 1465-1476.
8. Can, S.M., Aydin, Y., Turkmenoglu, O., et al.: Giant cell glioblastoma manifesting as traumatic intracerebral hemorrhage - case report. Neurol. Med. Chir. 2002; 42: 568-571.
9. Chang, C.C., Kuwana, N., Ito, S., et al.: Spinal leptomeningeal metastases of giant cell glioblastoma associated with subarachnoid hemorrhage: case report. J. Clin. Neurosci. 2001; 8: 56-59.
10. Dash, R.C., Provenzale, J.M., McComb, R.D., et al.: Malignant supratentorial ganglioglioma (ganglion cell - giant cell glioblastoma): a case report and review of the literature. Arch. Pathol. Lab. Med. 1999; 123:3 42-345.
11. De Prada, I., Cordobes, F., Azorín, D., et al.: Pediatric giant cell glioblastoma: a case report and review of the literature. Childs. Nerv. Syst. 2006; 22: 285-289.
12. Deb, P., Sharma, M.C., Chander, B., et al.: Giant cell glioblastoma: report of a case with prolonged survival and transformation to gliosarcoma. Childs. Nerv. Syst. 2006; 22: 314-319.
13. Deb, P., Sharma, M.C., Mahapatra, A.K., et al.: Glioblastoma multiforme with long term survival. Neurol. India 2005; 53: 329-332.
14. Demir, M.K., Hakan, T., Akinci, O., et al.: Primary cerebellar glioblastoma multiforme. Diagn. Interv. Radiol. 2005; 11: 83-86.
15. Fujita, M., Mizuno, M., Nagasaka, T., et al.: Aurora-B dysfunction of multinucleated giant cells in glioma detected by site-specific phosphorylated antibodies. J. Neurosurg. 2004; 101: 1012-1017.
16. Gandolfi, A., Tedeschi, F., Brizzi, R.: Cytology of giant-cell glioblastoma. Acta Cytol. 1983; 27: 193-197.
17. Grisold, W., Pernetzky, G., Jellinger, K.: Giant-cell glioblastoma of the thoracic cord. Acta Neurochir. 1981; 58: 121-126.
18. Huang, M.C., Kubo, O., Tajika, Y., et al.: A clinico-immunohistochemical study of giant cell glioblastoma. Noshuyo Byori 1996; 13: 11-16.
19. Hunter, S.B., Bandea, C., Swan, D., et al.: Mutations in the p53 gene in human astrocytomas: detection by single-strand conformation polymorphism analysis and direct DNA sequencing. Mod. Pathol. 1993; 6: 442-445.
20. Ibayashi, N., Herman, M.M., Boyd, J.C., et al.: Kinetics and glial fibrillary acidic protein production in a transplantable human giant cell glioblastoma (D-212 MG) of near haploid karyotype maintained in an organ culture system. An immunohistochemistry study. Neuropathol. Appl. Neurobiol. 1990; 16: 27-37.
21. Katoh, M., Aida, T., Sugimoto, S., et al.: Immunohistochemical analysis of giant cell glioblastoma. Pathol. Int. 1995; 45: 275-282.
22. Kawano, H., Kubota, T., Sato, K., et al.: Immunohistochemical study of giant cell in glioblastoma. Clin. Neuropathol. 1995; 14: 118-123.
23. Kepes, J.J.: Cellular whorls in brain tumors other than meningiomas. Cancer 1976; 37: 2232-2237.
24. Kimura, T., Budka, H., Soler-Federsppiel, S.: An immunocytochemical comparison of the glia-associated proteins glial fibrillary acidic protein and S-100 protein in human brain tumors. Clin. Neuropathol. 1986; 5: 21-27.
25. Kleihues, P., Ohgaki, H.: Phenotype vs genotype in the evolution of astrocytic brain tumors. Toxicol. Pathol. 2000; 28: 164-170.
26. Klein, R., Molenkamp, G., Sorensen, N., et al.: Favorable outcome of giant cell glioblastoma in a child. Report of an 11-year survival period. Childs. Nerv. Syst. 1998; 14: 288-291.
27. Kroh, H., Matyja, E., Marchel, A., et al.: Heavily lipidized, calcified giant cell glioblastoma in an 8-year-old patient, associated with neurofibromatosis type 1: report of a case with long-term survival. Clin. Neuropathol. 2004; 23: 286-291.
28. th edition. Philadelphia; Elsevier Saunders, 2005; pp. 269-342.
29. Maeda, K., Mizuno, M., Wakabayashi, T., et al.: Morphological assessment of the development of multinucleated giant cells in glioma by using mitosis-specific phosphorylated antibodies. J. Neurosurg. 2003; 854-859.
30. Margetts, J.C., Kalyan-Raman, U.P.: Giant-celled glioblastoma of brain. A clinico-pathological and radiological study of ten cases (including immunohistochemistry and ultrastructure). Cancer 1989; 63: 524-531.
31. Martínez-Díaz, H., Kleinschmidt-DeMasters, B.K., Powell, S.Z., et al.: Giant cell glioblastoma and pleomorphic xanthoastrocytoma show different immunohistochemical profiles for neuronal antigens and p53 but share reactivity for class III beta-tubulin. Arch. Pathol. Lab. Med. 2003; 127: 1187-1191.
32. McKeever, P.E., Chronwall, B.M., Houff, S.A., et al.: Glial and divergent cells in primate central nervous system tumors induced by JC virus isolated from human progressive multifocal leukoencephalopathy. Prog. Clin. Biol. Res. 1983; 105: 239-251.
33. McKeever, P.E.: Insights about brain tumors gained through immunohistochemistry and in situ hybridization of nuclear and phenotypic markers. J. Histochem. Cytochem. 1998; 46: 585-594.
34. Meyer-Puttlitz, B., Hayashi, Y., Waha, A., et al.: Molecular genetic analysis of giant cell glioblastomas. Am. J. Pathol. 1997; 151: 853-857.
35. Muller, W., Slowik, F., Firsching, R., et. Al.: Contribution to the problem of giant cell astrocytomas. Neurosurg. Rev. 1987; 10: 213-219.
36. Ohgaki, H., Peraud, A., Nakazato, Y., et al.: Giant cell glioblastoma. In Kleihues, P., Cavenee, W.K. (eds). World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system. Lyon; IARC Press, pp. 40-41.
37. Palma, L., Celli, P., Maleci, A., et al.: Malignant monstrocellular brain tumors. A study of 42 surgically treated cases. Acta Neurochir. 1989; 97: 17-25.
38. Parekh, H.C., Sharma, R.R., Prabhu, S.S., et al.: Multifocal giant cell glioblastoma: case report. Surg. Neurol. 1993; 40: 151-154.
39. Peraud, A., Watanabe, K., Plate, K.H., et al.: p53 mutations versus EGF receptor expression in giant cell glioblastomas. J. Neuropathol. Exp. Neurol. 1997; 56: 1236-1241.
40. Peraud, A., Watanabe, K., Schwechheimer, K., et al.: Genetic profile of the giant cell glioblastoma. Lab. Invest. 1999; 79: 123-129.
41. Queiroz, L.S., Faria, A.V., Zanardi, V.A., et al.: Lipidized giant-cell glioblastoma of cerebellum. Clin. Neuropathol. 2005; 24: 262-266.
42. Reis, R.M., Nakamura, M., Masuoka, J., et al.: Mutation analysis of hBUB1, HBUBR1 and hBUB3 genes in glioblastomas. Acta Neuropathol. 2001; 101: 297-304.
43. Reyaz, N., Tayyab, M., Khan, S.A., et al.: Correlation of glial fibrillary acidic protein with grading of the neuroglial tumours. J. Coll. Physicians Sur. Pak. 2005; 15: 472-475.
44. Sabel, M., Reifenberger, J., Weber, R.G., et al.: Long-term survival of a patient with giant cell glioblastoma. Case report. J. Neurosurg. 2001; 94: 605-611.
45. Sasaki, T., Lopes, M.B., Hankins, G.R., et al.: Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system. Acta Neuropathol. 2002; 104: 105-109.
46. Shinmura, F., Chen, M., Itoh, T., et al.: An autopsy case of extraneural metastases of giant cell glioblastoma with intracerebral hemorrhage. [in Japanese] No Shinkei Geka 1985; 13: 1245-1250.
47. Shinojima, N., Kochi, M., Hamada, J., et al.: The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme. J. Neurosurg. 2004; 101: 219-226.
48. Tascos, N.A., Parr, J., Gonatas, N.K.: Immunocytochemical study of the glial fibrillary acidic protein in human neoplasms of the central nervous system. Hum. Pathol. 1982; 13: 454-458.
49. Tekkok, I.H., Sav, A.: Anaplastic pleomorphic xanthoastrocytomas. Review of the literature with reference to malignancy potential. Pediatr. Neurosurg. 2004; 40:1 71-181.
50. Wadhwa, S., Nag, T.C., Jindal, A.: Expression of the neurotrophin receptors Trk A and Trk B in adult human astrocytoma and glioblastoma. J. Biosci. 2003; 28: 181-188.
51. Yoshida, T., Kawano, N., Oka, H., et al.: Clinical cure of glioblastoma. Two case reports. Neurol. Med. Chir. 2000; 40: 224-229.